Amniotic Membranes
What is an Amniotic Membrane Treatment in Mississauga and what makes it effective?
Ophthalogix Canada’s Amniotic Membrane is a Health Canada-approved therapeutic device used to provide quick symptom relief and healing of ocular surface disease. It is made from amniotic membrane, which has remarkable healing properties. It has been clinically proven to treat the following anterior eye conditions:
- Moderate to severe dry eye
- Filamentary Keratitis
- Exposure Keratopathy
- Herpetic Keratitis
- Neurotrophic Persistent Epithelial Defect
- Chemical-/thermal burns
- Salzmann’s Nodular Degeneration
- Stevens-Johnson Syndrome
- Recurrent Corneal Erosions
- Severe Infectious Keratitis
- Corneal Ulcers
- Post PRK Haze
- Severe Corneal Wounds
- Corneal Abrasions/Dystrophies
- Post DSEK for Bullous Keratopathy/Descemetocele
The two versions used in our clinic are the Aurora and the Eclipse. The thin membrane is placed on the eye after local anesthetic drops and remains there for 3 to 6 days until it is absorbed by the cornea. A contact lens is placed over the membrane to hold it in place, which is easily removed, typically after 7 days.
Corneal Healing Treatment Mississauga
FDA approved for:
- Anti-scarring (scarring reduces vision)
- Wound healing (ulcers and epithelial defects)
- Anti-inflammation (inflammation causes pain and secondary tissue damage)
- Anti-angiogenesis (i.e. blood vessel growth resistance, because the cornea is normally devoid of blood vessels and needs to remain an avascular structure to preserve its optical clarity)
“Ophthalogix’s amniotic membrane products are biologic tissue products used to support healing and comfort of the ocular surface. In Canada, products derived from human tissue, like amniotic membranes, are regulated under Health Canada’s medical device and tissue regulations, for example, the Safety of Human Cells, Tissues and Organs for Transplantation Regulations and the Medical Devices Regulations, rather than as traditional drugs.”
Amniotic membranes go beyond symptom management to modulate inflammation and prevent scarring on the surface of your eye. Treating the ocular surface can be challenging, but results with these membrane applications have been game-changing. Traditional options typically address inflammation or management of healing, but not both, and many have adverse side effects. Symptom relief typically lasts from 6 to 18 months, depending on the severity of the condition treated. For more information, feel free to visit Ophthalogix Canada.
